MedTalk: New EBV–MS project video now live on clinical trials
We are pleased to share the first MedTalk video from the EBV-MS project, now available on clinical trials. This new video marks the launch of a series featuring leading researchers and clinicians involved in the EBV-MS project.
By: Nele Vanbilsen (EMSP)
Published:
In this episode, experts discuss the scientific rationale behind focusing on EBV, a highly common virus that infects the vast majority of the global population, and its possible interaction with immune and genetic factors that may contribute to MS development. The discussion highlights why understanding these mechanisms is a key priority in current MS research.
The EBV-MS project brings together multidisciplinary expertise across neurology, virology, immunology, and data science to better understand disease pathways and identify potential avenues for future prevention and treatment strategies.
Beyond the scientific insights, the MedTalk series aims to increase transparency and accessibility in research by giving a voice directly to the scientists driving the work. This helps bridge the gap between ongoing clinical research and the wider MS community.